![Acrivon Therapeutics Inc](/common/images/company/N_ACRV.png)
Acrivon Therapeutics Inc (ACRV)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||||
Total Assets | 87.71M | 181.23M | 170.2M | 160.05M | 151.09M | 138.27M | 120.52M |
Total Current Assets | 78.67M | 132.1M | 123.96M | 153.28M | 144.49M | 129.69M | 112.14M |
Cash and Equivalents | 32.08M | 29.52M | 27.49M | 38.07M | 29.86M | 36.02M | 24.61M |
Total Non-Current Assets | 11.19M | 51.22M | 48.23M | 8.74M | 8.6M | 12.05M | 11.79M |
Total Liabilities | 10.81M | 10.75M | 9.73M | 10.87M | 12.94M | 17.07M | 12.54M |
Total Current Liabilities | 6.39M | 6.52M | 5.68M | 7.02M | 9.3M | 13.3M | 9.04M |
Total Non-Current Liabilities | 4.42M | 4.24M | 4.05M | 3.85M | 3.64M | 3.77M | 3.5M |
Common Equity | 2k | 22k | 22k | 22k | 22k | 23k | 23k |
Retained Earnings | -47.1M | -56.03M | -68.79M | -82.7M | -97.17M | -116.42M | -132.91M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 106.59M | 181.23M | 138.27M |
Total Current Assets | 100.41M | 132.1M | 129.69M |
Cash and Equivalents | 99.6M | 29.52M | 36.02M |
Total Non-Current Assets | -23.81M | 170.48M | 121.2M |
Total Liabilities | 7.88M | 10.75M | 17.07M |
Total Current Liabilities | 2.91M | 6.52M | 13.3M |
Total Non-Current Liabilities | 4.96M | 4.24M | 3.77M |
Total Equity | -23.81M | 170.48M | 121.2M |
Common Equity | 4k | 22k | 23k |
Retained Earnings | -24.87M | -56.03M | -116.42M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.